New insights of LncRNAs fingerprints in breast cancer progression: Tumorigenesis, drug resistance, and therapeutic opportunities

被引：2
作者：
Hussen, Bashdar Mahmud [1 ,2 ]
Othman, Diyar Idris [1 ]
Abdullah, Snur Rasool [2 ]
Khudhur, Zhikal Omar [3 ]
Samsami, Majid [4 ]
Taheri, Mohammad [5 ,6 ]
机构：
[1] Hawler Med Univ, Coll Pharm, Dept Clin Anal, Erbil 44001, Kurdistan Regio, Iraq
[2] Lebanese French Univ, Coll Hlth Sci, Dept Med Lab Sci, Erbil, Kurdistan Regio, Iraq
[3] Tishk Int Univ, Fac Educ, Dept Biol, Erbil, Kurdistan Regio, Iraq
[4] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran
[5] Jena Univ Hosp, Inst Human Genet, Jena, Germany
[6] Shahid Beheshti Univ Med Sci, Res Inst Urol & Nephrol, Urol & Nephrol Res Ctr, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 2025年 / 287卷
关键词：
Keywords; Breast cancer; LncRNAs; Tumorigenesis; Drug resistance; Clinical trial; LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; CELL-PROLIFERATION; PROMOTES PROLIFERATION; ADRIAMYCIN RESISTANCE; UP-REGULATION; INVASION; MIGRATION; METASTASIS;
D O I：
10.1016/j.ijbiomac.2024.138589
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Breast cancer (BC) is one of the common female cancers and it is characterized by considerable problems regarding its development and therapy. Long non-coding RNAs (lncRNAs) have been identified as significant modulators in BC development, especially, in tumorigenicity and chemoresistance. We therefore endeavor to present an up-to-date understanding of lncRNAs and their impact on BC progression and treatment, concerning molecular processes, treatment options, and use as a therapeutic opportunity. LncRNAs are novel regulators of genes that cause therapeutic resistance and directly impact the functioning of both coding and non-coding genes in BC patients, but little is known about their mechanisms of actions. Thus, additional study is required to have a deeper understanding of their modes of action and possible roles in BC disease. This study aims to investigate the functions of lncRNAs in the development of BC, with particular attention to their role in tumorigenesis, drug resistance mechanisms, and therapeutic targets. This will help to identify novel therapeutic targets and improve the effectiveness of BC treatment.
引用
收藏
页数：29
相关论文
共 50 条
[21]   Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance [J].
Lei, Pan ;
Wang, Wenzhou ;
Sheldon, Marisela ;
Sun, Yutong ;
Yao, Fan ;
Ma, Li .
CANCERS, 2023, 15 (13)
[22]   New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer [J].
Khaled, Noura ;
Bidet, Yannick .
CANCERS, 2019, 11 (04)
[23]   Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance [J].
Nawrocki, Steffan T. ;
Wang, Wei ;
Carew, Jennifer S. .
CANCERS, 2020, 12 (10)
[24]   EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions [J].
Hashemi, Mehrdad ;
Arani, Hamid Zaferani ;
Orouei, Sima ;
Fallah, Shayan ;
Ghorbani, Amin ;
Khaledabadi, Maryam ;
Kakavand, Amirabbas ;
Tavakolpournegari, Alireza ;
Saebfar, Hamidreza ;
Heidari, Hajar ;
Salimimoghadam, Shokooh ;
Entezari, Maliheh ;
Taheriazam, Afshin ;
Hushmandi, Kiavash .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
[25]   Inflammasomes in breast cancer: the ignition spark of progression and resistance? [J].
Elgohary, Sawsan ;
El Tayebi, Hend M. .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2023, 25
[26]   Functional miRNAs in breast cancer drug resistance [J].
Hu, Weizi ;
Tan, Chunli ;
He, Yunjie ;
Zhang, Guangqin ;
Xu, Yong ;
Tang, Jinhai .
ONCOTARGETS AND THERAPY, 2018, 11 :1529-1541
[27]   Insights on the Role of Polyphenols in Combating Cancer Drug Resistance [J].
Farhan, Mohd .
BIOMEDICINES, 2023, 11 (06)
[28]   The Role of Non-Coding RNAs in Breast Cancer Drug Resistance [J].
Tian, Jin-hai ;
Liu, Shi-hai ;
Yu, Chuan-yang ;
Wu, Li-gang ;
Wang, Li-bin .
FRONTIERS IN ONCOLOGY, 2021, 11
[29]   New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer [J].
Ahmed, Munazza ;
Daoud, Grace Hope ;
Mohamed, Asmaa ;
Harati, Rania .
GENES, 2021, 12 (05)
[30]   Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets [J].
Suliman, Muath ;
Saleh, Raed Obaid ;
Chandra, Muktesh ;
Rasool, Khetam Habeeb ;
Jabir, Majid ;
Jawad, Sabrean F. ;
Hasan, Thikra F. ;
Singh, Mithilesh ;
Singh, Manmeet ;
Singh, Abhayveer .
MEDICAL ONCOLOGY, 2025, 42 (04)
12345